ALLISON BERTKEN: Open Payments
NPI 1730646647 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $356 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $109 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| Myriad Genetic Laboratories, Inc. | 1 | $96 |
| ABBVIE INC. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Exelixis Inc. | 1 | $23 |
| GENZYME CORPORATION | 1 | $19 |
Products named: KEYTRUDA, MYRISK, KISQALI, EPKINLY, ALUNBRIG, PLUVICTO, LIBTAYO, CABOMETYX.
Industry payments across MO — which companies pay providers there.
